Endothelial dysfunction and oxidative stress in chronic renal failure

Journal of Nephrology

Volumn 17, Issue 4, 2004, Pages 512-519

  Ghiadoni, Lorenzo ^a   Cupisti, Adamasco ^a   Huang, Yale ^a   Mattei, Paola ^b   Cardinal, Heloise ^a   Favilla, Stefania ^a   Rindi, Paolo ^b   Barsotti, Giuliano ^a   Taddei, Stefano ^a   Salvetti, Antonio ^a  

^a UNIVERSITY OF PISA   (Italy)

^b UNIVERSITY HOSPITAL OF PISA   (Italy)

Author keywords

Blood vessels; Chronic kidney disease; Endothelium; Hemodialysis; Oxidative stress; Vitamin C

Indexed keywords

ANTIHYPERTENSIVE AGENT; ANTIOXIDANT; ASCORBIC ACID; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; CLONIDINE; CREATININE; ERYTHROPOIETIN; GLYCERYL TRINITRATE; LOOP DIURETIC AGENT;

ADULT; ARTERY DILATATION; ARTERY ENDOTHELIUM; ARTICLE; BRACHIAL ARTERY; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CHRONIC KIDNEY FAILURE; COMPUTER ANALYSIS; CONSERVATIVE TREATMENT; CREATININE BLOOD LEVEL; CREATININE CLEARANCE; DISEASE SEVERITY; DOSE RESPONSE; DRUG RESPONSE; ECHOGRAPHY; ENDOTHELIUM LESION; FEMALE; FOREARM BLOOD FLOW; HEMODIALYSIS; HUMAN; HYPEREMIA; HYPERTENSION; INCIDENCE; MAJOR CLINICAL STUDY; MALE; OXIDATIVE STRESS; UREMIA;

ADULT; AGED; ANTIHYPERTENSIVE AGENTS; ASCORBIC ACID; BRACHIAL ARTERY; CASE-CONTROL STUDIES; DISEASE PROGRESSION; ENDOTHELIUM, VASCULAR; EPOETIN ALFA; FEMALE; FOLLOW-UP STUDIES; HUMANS; KIDNEY FAILURE, CHRONIC; KIDNEY FUNCTION TESTS; MALE; MIDDLE AGED; OXIDATIVE STRESS; REFERENCE VALUES; RENAL DIALYSIS; RISK ASSESSMENT; SAMPLING STUDIES; SEVERITY OF ILLNESS INDEX; TREATMENT OUTCOME; VASODILATION;

EID: 4644356535     PISSN: 11218428     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (45)

1. Lüscher TF, Vanhoutte PM Eds. The endothelium: modulator of cardiovascular function. Boca Raton, Fla: CRC Press 1990; 1-215.
2. Celermajer DS, Adams MR, Clarkson P, Robinson J, McCredie R, Donald A, Deanfield JE. Passive smoking and impaired endothelium-dependent arterial dilatation in healthy young adults. N Engl J Med 1996; 334: 150-4.
3. Celermajer DS, Sorensen KE, Gooch VM, Spiegelhalter DJ, Miller OI, Sullivan ID, Lloyd JK, Deanfield JE. Non-invasive detection of endothelial dysfunction in children and adults at risk of atherosclerosis. Lancet 1992; 340: 1111-5.
4. Ting HH, Timimi FK, Haley EA, Roddy MA, Ganz P, Creager MA. Vitamin C improves endothelium-dependent vasodilation in forearm resistance vessels of humans with hypercholesterolemia. Circulation 1997; 95: 2617-22.
5. Taddei S, Virdis A, Mattei P, Salvetti A. Vasodilation to acetylcholine in primary and secondary forms of human hypertension. Hypertension 1993; 21: 929-33.
6. Taddei S, Virdis A, Ghiadoni L, Magagna A, Salvetti A. Vitamin C improves endothelium dependent vasodilation by restoring nitric oxide activity in essential hypertensive patients. Circulation 1998; 97: 2222-9.
7. Ting HH, Timimi FK, Boles KS, Creager SJ, Ganz P, Creager MA. Vitamin C improves endothelium-dependent vasodilation in patients with non-insulin-dependent diabetes mellitus. J Clin Invest 1996; 97: 22-8.
8. Suwaidi JA, Hamasaki S, Higano ST, Nishimura RA, Holmes DR Jr, Lerman A. Long-term follow-up of patients with mild coronary artery disease and endothelial dysfunction. Circulation 2000; 101: 948-54.
9. Schachinger V, Britten MB, Zeiher AM. Prognostic impact of coronary vasodilator dysfunction on adverse long-term outcome of coronary heart disease. Circulation 2000; 101: 1899-906.
10. Neunteufl T, Heher S, Katzenschlager R, Wolfl G, Kostner K, Maurer G, Weidinger F. Late prognostic value of flow-mediated dilation in the brachial artery of patients with chest pain. Am J Cardiol 2000; 86: 207-10.
11. Lindner A, Charra B, Sherrard DJ, Scribner BH. Accelerated atherosclerosis in prolonged maintenance hemodialysis. N Engl J Med 1974; 290: 697-701.
12. Luke RG. Chronic renal failure - a vasculopathic state. N Engl J Med 1998; 339: 841-3.
13. Kari JA, Donald AE, Vallace DT, Bruckdorfer KR, Leone A, Mullen MJ, Bunce T, Dorado B, Deanfield JE, Rees L. Physiology and biochemistry of endothelial function in children with chronic renal failure. Kidney Int 1997; 52: 468-72.
14. van Guldener C, Lambert J, Jansen MJ, Steyn M, Donker AJ, Stehouwer CD. Endothelium dependent vasodilation is impaired in peritoneal dialysis patients. Nephrol Dial Transplant 1998; 13: 1782-6.
15. van Guldener C, Lambert J, Jansen MJ, Donker AJ, Stehouwer CD. Endothelium dependent vasoditation and distensibility of large arteries in chronic hemodialysis patients. Nephrol Dial Transplant 1997; 12 (suppl 2): S14-8.
16. Joannides R, Bakkali RH, LeRoy F, Rivault O, Godin M, Moore N, Fillastre JP, Thuillez C. Altered flow dependent vasodilation of conduit arteries in maintenance hemodialysis. Nephrol Dial Transplant 1997; 12: 2623-8.
17. Morris ST, McMurray JJ, Rodger RS, Jardine AG. Impaired endothelium-dependent vasodilation in uremia. Nephrol Dial Transplant 2000; 16: 1194-200.
18. Annuk M, Lind L, Linde T, Fellström B. Impaired endothelium-dependent vasodilatation in renal failure in humans. Nephrol Dial Transplant 2001; 16: 302-6.
19. Richard MJ, Arnaud J, Jurkovitz C, Hachache T, Meftahi H, Laporte F, Foret M, Favier A, Cordonnier D. Trace elements and lipid peroxidation abnormalities in patients with chronic renal failure. Nephron 1991; 57: 10-5.
20. Bochev P, Tzvetkov N, Alexandrova M, Magrisso M, Bechev B, Monovich O, Markova V. Development of oxidative stress in chronic kidney insufficiency following the progression of disease. Nephron 1997; 77: 244-5.
21. Taylor JE, Scott N, Bridges A, Henderson IS, Stewart WK, Belch JJ. Lipid peroxidation and antioxidants in continuous ambulatory dialysis patients. Perit Dial Int 1992; 12: 252-6.
22. Witko-Sarsat V, Friedlander M, Capeillere-Blandin C, Nguyen-Khoa T, Nguyen AT, Zingraff J, Jungers P, Descamps-Latscha B. Advanced oxidation protein products as a novel marker of oxidative stress in uremia. Kidney Int 1996; 49: 1304-13.
23. Williams MJ, Sutherland WH, McCormick MP, de Jong SA, McDonald JR, Walker RJ. Vitamin C improves endothelial dysunction in renal allograft recipients. Nephrol Dial Transplant 2001; 16: 1251-5.
24. Cross JM, Donald AE, Nuttall SL, Deanfield JE, Woolfson RG, Macallister RJ. Vitamin C improves resistance but not conduit artery endothelial function in patients with chronic renal failure. Kidney Int 2003; 63: 1433-42.
25. Taddei S, Virdis A, Ghiadoni L, Sudano I, Salvetti A. Effects of antihypertensive drugs on endothelial dysfunction: clinical implications. Drugs 2002; 62: 265-84.
26. Esterbauer H, Cheeseman KH. Determination of aldehydic lipid peroxidation products: malonaldehyde and 4-hydroxynonenal. Methods Enzymol 1990; 186: 407-21.
27. Jiang ZY, Hunt JV, Wolff SP. Ferrous ion oxidation in the presence of xylenol orange for detection of lipid hydroperoxide in low density lipoprotein. Anal Biochem 1992; 202: 384-9.
28. Benzie IF, Strain JJ. The ferric reducing ability of plasma (FRAP) as a measure of "antioxidant power": the FRAP assay. Ann Biochem 1996; 239: 70-6.
29. Virdis A, Ghiadoni L, Cardinal H, Favilla S, Duranti P, Birindelli R, Magagna A, Bernini G, Salvetti G, Taddei S, Salvetti A. Mechanisms responsible for endothelial dysfunction induced by fasting hyperhomocystinemia in normotensive subjects and patients with essential hypertension. J Am Coll Cardiol 2001; 38: 1106-15.
30. Ghiadoni L, Huang Y, Magagna A, Buralli S, Taddei S, Salvetti A. Effect of acute blood pressure reduction on endothelial function in the brachial artery of patients with essential hypertension. J Hypertens 2001; 19: 547-51.
31. Beux F, Carmassi S, Salvetti MV, Ghiadoni L, Huang Y, Taddei S, Salvetti A. Automatic evaluation of arterial diameter variation from vascular echographic images. Ultrasound Med Biol 2001; 27: 1621-9.
32. Peuchant E, Carbonneau MA, Dubourg L, Thomas MJ, Perromat A, Vallot C, Clerc M. Lipoperoxidation in plasma and red blood cells of patients undergoing hemodialysis: vitamins A, E, and iron status. Free Radic Biol Med 1994; 16: 339-46.
33. Daschner M, Lenhartz H, Botticher D, Schaefer F, Wollschlager M, Mehls O, Leichsenring M. Influence of dialysis on plasma lipid peroxidation products and antioxidant levels. Kidney Int 1996; 50: 1268-72.
34. Panichi V, Migliori M, De Pietro S, Taccola D, Andreini B, Metelli MR, Giovannini L, Palla R. The link of biocompatibility to cytokine production. Kidney Int 2000; 58 (suppl 76): S96-103.
35. Miyazaki H, Matsuoka H, Itabe H, Usui M, Ueda S, Okuda S, Imaizumi T. Hemodialysis impairs endothelial function via oxidative stress. Effect of vitamin E-coated dialyzer. Circulation 2001; 101: 1002-6.
36. Kosch M, Levers A, Barenbrock M, Matzkies F, Schaefer RM, Kisters K, Rahn KH, Hausberg M. Acute effects of hemodialysis on endothelial function and large artery elasticity. Nephrol Dial Transplant 2001; 16: 1663-8.
37. Levine GN, Frei B, Koulouris SN, Gerhard MD, Keaney JF Jr, Vita JA. Ascorbic acid reverses endothelial vasomotor dysfunction in patients with coronary artery disease. Circulation 1996; 93: 1107-13.
38. Sydow K, Schwedhelm E, Arakawa N, Bode-Boger SM, Tsikas D, Hornig B, Frolich JC, Boger RH. ADMA and oxidative stress are responsible for endothelial dysfunction in hyperhomocyst(e)inemia: effects of L-arginine and B vitamins. Cardiovasc Res 2003; 57: 244-52.
39. Wada Y, Matsuoka H, Tamai O, Kohno K, Okuda S, Imaizumi T. Erythropoietin impairs endothelium-dependent vasorelaxation through cyclooxygenase-dependent mechanisms in humans. Am J Hypertens 1999; 12: 980-7.
40. Schmidt RJ, Baylis C. Total nitric oxide production is low in patients with chronic renal disease. Kidney Int 2000; 58: 1261-6.
41. Vallance P, Leone A, Calvet A, Collier J, Moncada S. Accumulation of an endogenous inhibitor of nitric oxide synthesis in chronic renal failure. Lancet 1992; 339: 572-5.
42. Zoccali C, Bode-Boger S, Mallamaci F, Benedetto F, Tripepi G, Malatino L, Cataliotti A, Bellanuova I, Fermo I, Frolich J, Boger R. Plasma concentration of asymmetrical dimethylarginine and mortality in patients with end-stage renal disease: a prospective study. Lancet 2001; 358: 2113-7.
43. Achan V, Broadhead M, Malaki M, Whitley G, Leiper J, MacAllister R, Vallance P. Asymmetric dimethylarginine causes hypertension and cardiac dysfunction in humans and is actively metabolized by dimethylarginine dimethylaminohydrolase. Arterioscler Thromb Vasc Biol 2003; 23: 1455-9.
44. Kielstein JT, Impraim B, Simmel S, Bode-Boger SM, Tsikas D, Frolich JC, Hoeper MM, Haller H, Fliser D. Cardiovascular effects of systemic nitric oxide synthase inhibition with asymmetrical dimethylarginine in humans. Circulation 2004; 109: 172-7.
45. Boaz M, Smatana S, Weinstein T, Matas Z, Gafter U, Iaina A, Knecht A, Weissgarten Y, Brunner D, Fainaru M, Green MS. Secondary prevention with antioxidants of cardiovascular disease in end-stage renal disease (SPACE): randomised placebo-controlled trial. Lancet 2000; 356: 1213-8.